Patent details

Basic Information

Publication number:

EP1229909

PCT Application Number:

PCT/US/01/17567

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019397512

PCT Publication Number:

WO/01/09172

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TRANSDERMAL DELIVERY OF LASOFOXIFENE

French Title of Invention:

ADMINISTRATION TRANSCUTANEE DE LASOFOXIFENE

German Title of Invention:

TRANSDERMALE VERABREICHUNG VON LASOFOXIFEN

SPC Number:

Dates

Filing date:

31/05/2001

Grant date:

12/11/2003

EP Publication Date:

12/11/2003

PCT Publication Date:

06/12/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/08/2002

EP B1 Publication Date:

12/11/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/05/2009

Expiration date:

31/05/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/05/2001

 

 

Name:

Watson Pharmaceuticals Inc.

Address:

311 Bonnie Circle, Corona, CA 92880, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

28/01/2004

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

QUAN Danyi

Address:

United States (US)

2

Name:

FIKSTAD David

Address:

United States (US)

Priority

Priority Number:

208789 P

Priority Date:

01/06/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/40;

Filing date	Document type	Number of pages